Weight Loss and Metabolic Health

Weight Loss and Metabolic Health

What Is Maintaining a Healthy Weight Important? 

Maintaining a healthy weight is crucial for overall health. It is well known that obesity is one of the leading causes of morbidity and mortality,1 associated with an array of health issues such as dyslipidemia (ie, imbalance of blood lipid levels), coronary artery disease (ie, diseases of the heart’s blood vessels), diabetes, sleep apnea, liver disease, and certain types of cancers.2

 

Weight Loss and Heart Health

Maintaining a healthy weight is important for heart health. Obesity is associated with various heart-related issues including dyslipidemia and coronary artery disease.1,2 Current guidelines note that body mass index is linearly associated with increased blood pressure,3 one of the major risk factors for cardiovascular disease,4,5 and that weight loss can significantly improve both blood pressure and lipid profile.3 Various studies have demonstrated this, with studies on weight loss in obese and overweight individuals with diabetes finding significant improvements in cardiovascular risk factors including improved blood pressure, triglyceride levels, high-density lipoprotein cholesterol levels, and glycemia.6 Guidelines recommend making changes to dietary patterns that yield 500-750 kcal/day energy deficit for weight loss, including increasing the intake of fruits and vegetables while decreasing the intake of ultra-processed foods and alcohol.

 

Weight Loss and Diabetes

There is strong evidence suggesting that obesity is the greatest risk factor for developing prediabetes and type 2 diabetes mellitus (T2DM), with estimates that nearly 90% of T2DM can be attributed to obesity.7 Excess visceral and abdominal adiposity are associated with metabolic abnormalities linked with the development of T2DM such as insulin resistance, pancreatic b-cell dysfunction, and dyslipidemia.8,9 On the other hand, a 5% weight loss has been shown to improve the insulin sensitivity of adipose tissue, the liver, and skeletal muscle as well as increase b-cell function.8,10 Rigorous randomized controlled trials have consistently shown that weight loss can help manage the illness and even delay the onset of T2DM.11–14 Individuals with T2DM should focus on making healthy lifestyle changes early on in their illness. The American Diabetes Association recommends eating a healthy diet and engaging in physical activity to achieve a 500-750 kcal/day energy deficit.15,16

 

Weight Loss and Metabolic Syndrome

Obesity, particularly abdominal obesity, is a defining characteristic of metabolic syndrome.17–19  The prevalence of metabolic syndrome often corresponds with the prevalence of obesity, and each component of the metabolic syndrome has been shown to be closely related to weight gain, especially abdominal adiposity and waist circumference.20,21 It is postulated that increased abdominal adiposity may be the primary trigger in the development of metabolic syndrome. Intra-abdominal fat plays an important endocrine role, and an increase in its mass can disrupt the release of hormonal factors that regulate metabolism. Thus, the management of metabolic syndrome heavily focuses on lifestyle changes that promote healthy weight loss.21 Studies have found that achieving weight loss (5-10% of body weight) through diet and exercise can significantly improve all components of metabolic syndrome.21–24


References:
1. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. N Engl J Med. 2017;377(1):13-27. doi:10.1056/NEJMoa1614362
2. Mitchell N, Catenacci V, Wyatt HR, Hill JO. Obesity: Overview of an Epidemic. Psychiatr Clin North Am. 2011;34(4):717-732. doi:10.1016/j.psc.2011.08.005
3. Koskinas KC, Van Craenenbroeck EM, Antoniades C, et al. Obesity and Cardiovascular Disease: An Esc Clinical Consensus Statement. Eur Heart J. Published online August 30, 2024:ehae508. doi:10.1093/eurheartj/ehae508
4. Facts About Hypertension | cdc.gov. Centers for Disease Control and Prevention. July 6, 2023. Accessed July 21, 2023. https://www.cdc.gov/bloodpressure/facts.htm
5. Mills KT, Stefanescu A, He J. The Global Epidemiology of Hypertension. Nat Rev Nephrol. 2020;16(4):223-237. doi:10.1038/s41581-019-0244-2
6. Wing RR, Lang W, Wadden TA, et al. Benefits of Modest Weight Loss in Improving Cardiovascular Risk Factors in Overweight and Obese Individuals With Type 2 Diabetes. Diabetes Care. 2011;34(7):1481-1486. doi:10.2337/dc10-2415
7. Verma S, Hussain ME. Obesity and Diabetes: An Update. Diabetes Metab Syndr. 2017;11(1):73-79. doi:10.1016/j.dsx.2016.06.017
8. Magkos F, Fraterrigo G, Yoshino J, et al. Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans With Obesity. Cell Metab. 2016;23(4):591-601. doi:10.1016/j.cmet.2016.02.005
9. Zheng Y, Ley SH, Hu FB. Global Aetiology and Epidemiology of Type 2 Diabetes Mellitus and Its Complications. Nat Rev Endocrinol. 2018;14(2):88-99. doi:10.1038/nrendo.2017.151
10. Franz MJ. Weight Management: Obesity to Diabetes. Diabetes Spectr. 2017;30(3):149-153. doi:10.2337/ds17-0011
11. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin. N Engl J Med. 2002;346(6):393-403. doi:10.1056/NEJMoa012512
12. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-Year Follow-Up of Diabetes Incidence and Weight Loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374(9702):1677-1686. doi:10.1016/S0140-6736(09)61457-4
13. Nathan DM, Barrett-Connor E, Crandall JP, et al. Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866-875. doi:10.1016/S2213-8587(15)00291-0
14. Look AHEAD Research Group. Eight-Year Weight Losses with an Intensive Lifestyle Intervention: The Look Ahead Study. Obesity. 2014;22(1):5-13. doi:10.1002/oby.20662
15. Standards of Medical Care in Diabetes—2016 Abridged for Primary Care Providers. Clin Diabetes. 2016;34(1):3-21. doi:10.2337/diaclin.34.1.3
16. American Diabetes Association. 5. Lifestyle Management: Standards of Medical Care in Diabetes—2019. Diabetes Care. 2018;42(Supplement_1):S46-S60. doi:10.2337/dc19-S005
17. Regufe VMG, Pinto CMCB, Perez PMVHC. Metabolic Syndrome in Type 2 Diabetic Patients: A Review of Current Evidence. Porto Biomed J. 2020;5(6):e101. doi:10.1097/j.pbj.0000000000000101
18. Singer GM, Setaro JF. Secondary Hypertension: Obesity and the Metabolic Syndrome. J Clin Hypertens. 2008;10(7):567-574. doi:10.1111/j.1751-7176.2008.08178.x
19. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and Management of the Metabolic Syndrome. Circulation. 2005;112(17):e285-e290. doi:10.1161/CIRCULATIONAHA.105.169405
20. Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic Syndrome: Pathophysiology, Management, and Modulation by Natural Compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215-225. doi:10.1177/1753944717711379
21. Han TS, Lean ME. A Clinical Perspective of Obesity, Metabolic Syndrome and Cardiovascular Disease. JRSM Cardiovasc Dis. 2016;5:2048004016633371. doi:10.1177/2048004016633371
22. Masood W, Annamaraju P, Uppaluri KR. Ketogenic Diet. In: StatPearls. StatPearls Publishing; 2022. Accessed August 9, 2022. http://www.ncbi.nlm.nih.gov/books/NBK499830/
23. Alarim RA, Alasmre FA, Alotaibi HA, Alshehri MA, Hussain SA. Effects of the Ketogenic Diet on Glycemic Control in Diabetic Patients: Meta-Analysis of Clinical Trials. Cureus. 12(10):e10796. doi:10.7759/cureus.10796
24. Yuan X, Wang J, Yang S, et al. Effect of the Ketogenic Diet on Glycemic Control, Insulin Resistance, and Lipid Metabolism in Patients With T2DM: a Systematic Review and Meta-analysis. Nutr Diabetes. 2020;10(1):1-8. doi:10.1038/s41387-020-00142-z

  

(Disclaimer)

The content of this article is intended to provide a general information and knowledge on the subject matter. The views expressed in newsletters, articles, and blogs in the i-SENS USA website are not necessarily those of i-SENS Incorporated, i-SENS USA Incorporated or our publishers. Medical or nutritional information on i-SENS USA website is not intended to replace professional medical advice – you should always consult a specialist with any questions about your specific circumstances.

Add a comment